PeriOperative ISchemic Evaluation-2 Trial

  • Research type

    Research Study

  • Full title

    A large, international, placebo-controlled, factorial trial to assess the impact of low-dose clonidine and acetyl-salicyclic acid (ASA) in patients undergoing noncardiac surgery who are at risk of a perioperative cardiovascular event. PeriOperative ISchemic Evaluation-2 Trial.

  • IRAS ID

    66725

  • Contact name

    Balaji Packianathaswamy

  • Sponsor organisation

    Population Health Research Institute

  • Eudract number

    2009-018173-31

  • ISRCTN Number

    ISRCTN17233551

  • Clinicaltrials.gov Identifier

    NCT00860925

  • Research summary

    During the last few decades, substantial advances in noncardiac surgery have improved disease treatment and patients?? quality of life. As a result, the number of patients undergoing noncardiac surgery is growing. A recent study that used surgical data from 56 countries suggests that 200 million major noncardiac surgical procedures are undertaken annually around the world. Noncardiac surgery is associated with major vascular complications (i.e., vascular death, nonfatal myocardial infarction [MI], nonfatal cardiac arrest, and nonfatal stroke). Worldwide, approximately 3-5 million adult patients annually suffer a major perioperative vascular complication in the first 30 days after surgery. There is not a single established effective and safe intervention to prevent major perioperative vascular complications. The striking absence of prophylactic interventions reflects the paucity of large randomized controlled trials (RCTs) evaluating perioperative interventions. Major perioperative vascular complications are therefore a major neglected public health problem. There are encouraging laboratory, physiology, operative and non-operative data suggesting that perioperative low-dose clonidine and low-dose acetyl-salicylic acid (ASA) may prevent all-cause mortality and nonfatal MI without excessive risk of major bleeding and clinically important hypotension. We will undertake a large international factorial RCT to establish the effects of these 2 interventions in patients undergoing noncardiac surgery.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    10/H1306/85

  • Date of REC Opinion

    8 Feb 2011

  • REC opinion

    Further Information Favourable Opinion